Skip to content

Study on the Correlation between Heparanase and Ventricular Remodeling, Myocardial Fibrosis and Mitochondrial Autophagy after Myocardial Ischemia-reperfusion

Study on the Correlation between Heparanase and Ventricular Remodeling, Myocardial Fibrosis and Mitochondrial Autophagy after Myocardial Ischemia-reperfusion

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600125987
Enrollment
Unknown
Registered
2026-06-02
Start date
2026-06-02
Completion date
Unknown
Last updated
2026-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myocardial ischemia-reperfusion, ventricular remodeling, myocardial fibrosis

Interventions

The ventricular remodeling group after myocardial ischemia-reperfusion:None
The non-ventricular remodeling group after myocardial ischemia-reperfusion:None

Sponsors

The 960 Hospital of the Joint Logistics Support Force of the Chinese People's Liberation Army
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1.The diagnostic criteria for STEMI are met: history of chest pain, characteristic changes on electrocardiogram, and elevation of myocardial necrosis markers. 2.Emergency PCI shows: at least one main coronary artery is occluded, and TIMI grade 0. 3.After emergency PCI: the occluded vessel is re-opened, and blood flow returns to TIMI grade 1, 2, and 3 must all be satisfied simultaneously.

Exclusion criteria

Exclusion criteria: 1.Does not meet the inclusion criteria. 2.Severe cardiovascular or pulmonary diseases, liver or kidney dysfunction, severe infections, malignant tumors. 3.Allergic to the drugs related to the trial, having used drugs that may affect the level of HPSE recently, such as anticoagulants, antiplatelet drugs, anti-inflammatory drugs, etc. 4.Has a recent history of myocardial infarction, has undergone PCI or other cardiac surgeries, and the level of HPSE may be in an abnormal state. 5.Pregnant or lactating women, those with mental or neurological disorders who cannot cooperate to complete the study; incomplete clinical data. Any one of the above conditions will result in exclusion.

Design outcomes

Primary

MeasureTime frame
Heparanase;

Secondary

MeasureTime frame
N-terminal pro-brain natriuretic peptide;Soluble growth-stimulating expression gene 2 protein;Matrix Metallopeptidase-9;

Countries

China

Contacts

Public ContactQun Jin

The 960 Hospital of the Joint Logistics Support Force of the Chinese People's Liberation Army

jinqun1998@163.com+86 138 6400 3305

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 11, 2026